Cover Image

Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Printing Office, 2002.
Subjects:	Pharmaceutical policy > United States. Prescription pricing > United States. Drugs > Law and legislation > United States. Legislative hearings.
Online Access:	https://purl.fdlp.gov/GPO/gpo89024

Similar Items

Prescription drug price inflation : are prices rising too fast? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, December 8, 2009.
Published: (2012)

Prescription drug importation /
by: Sarata, Amanda K., et al.
Published: (2018)

Comparison of reimbursement prices for multiple-source prescription drugs in the United States and Canada.
Published: (1991)

Prescription drug discount coupons and patient assistance programs (PAPs) /
by: Kirchhoff, Suzanne M.
Published: (2018)

Audits of Medicare prescription drug plan sponsors.
Published: (2011)

The Medicare drug benefit : are private insurers getting good discounts for the taxpayer? : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, second session, July 24, 2008.
Published: (2010)

Competition and the cost of Medicare's prescription drug program.
by: Cook, Anna, et al.
Published: (2014)

Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session.
Published: (2020)

Examining FDA's Prescription Drug User Fee Program.
Published: (2017)

Drug shortages : causes, FDA authority, and policy options /
by: Dabrowska, Agata
Published: (2018)

A prescription for savings : reducing drug costs to Medicare : hearing before the Special Committee on Aging, United States Senate, One Hundred Twelfth Congress, first session, Washington, DC, July 21, 2011.
Published: (2011)

Implementation of the Medicare drug benefit : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session,May 3 and May 4, 2006.
Published: (2011)

60 minutes.
Published: (2004)

Regulatory exclusivity reform in the 115th Congress /
by: Thomas, John R., 1967-
Published: (2019)

Comparing special needs plan beneficiaries to other Medicare advantage prescription drug plan beneficiaries.
Published: (2008)

Counterfeit Drugs : Fighting Illegal Supply Chains.
Published: (2014)

Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019.
Published: (2021)

Replacing average wholesale price : Medicaid drug payment policy.
Published: (2011)

Calculation of volume-weighted average sales price for Medicare Part B prescription drugs.
Published: (2006)

Medicare prescription drug sponsors' training to prevent fraud, waste, and abuse.
Published: (2011)

The Proposed Drug Quality and Security Act (H.R. 3204) /
by: Thaul, Susan
Published: (2020)

Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019.
Published: (2021)

Medicare payments for currently covered prescription drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, October 3, 2002.
Published: (2003)

Options for safe and effective prescription drug importation : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighth Congress, second session, March 11, 2004.
Published: (2012)

Generic drug utilization in state Medicaid programs.
Published: (2006)

Prescription Drug User Fee Act (PDUFA) : 2017 reauthorization as PDUFA VI /
by: Dabrowska, Agata, et al.
Published: (2018)

Prescription Drug User Fee Act (PDUFA) : 2012 reauthorization as PDUFA V /
by: Thaul, Susan
Published: (2019)

Perspectives of drug manufacturers : investigational new drug and new drug applications.
Published: (1990)

Generic drug utilization in the Medicare Part D program.
Published: (2007)

Monitoring Medicare Part B drug prices : a comparison of average sales prices to average manufacturer prices.
Published: (2006)

Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
Published: (2018)

The Prescription Drug User Fee Act : structure and reauthorization issues /
by: Vogt, Donna U., et al.
Published: (2020)

Perspectives of drug manufacturers : abbreviated new drug applications.
Published: (1990)

Omission of drugs from the federal upper limit list in 2001.
Published: (2004)

Midyear formulary changes in Medicare prescription drug plans.
Published: (2009)

The impact of high-priced generic drugs on Medicare and Medicaid.
Published: (1998)

Direct-to-consumer advertising : marketing, education, or deception? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 8, 2008.
Published: (2008)

Drug Regulation Reform Act of 1978 : the administration proposal : section-by-section analysis, H.R. 11611 and S. 2755, 95th Congress, second session.
Published: (1978)

Medicare payments for newly available generic drugs.
Published: (2011)

Prescription drug plan sponsors' compliance plans.
Published: (2006)